107 related articles for article (PubMed ID: 10668499)
1. BRCA 1/2 gene mutation testing-based cancer prevention and the moral concerns of different types of patients.
Goelen G; Rigo A; Bonduelle M; De Grève J
Ann N Y Acad Sci; 1999; 889():240-3. PubMed ID: 10668499
[No Abstract] [Full Text] [Related]
2. Mutations of the BRCA1 and BRCA2 genes and the possibilities for predictive testing.
Gayther SA; Ponder BA
Mol Med Today; 1997 Apr; 3(4):168-74. PubMed ID: 9134530
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations.
Ganguly A; Leahy K; Marshall AM; Dhulipala R; Godmilow L; Ganguly T
Genet Test; 1997; 1(2):85-90. PubMed ID: 10464631
[TBL] [Abstract][Full Text] [Related]
4. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
[TBL] [Abstract][Full Text] [Related]
5. Oncogenetic information in the hands of physicians and the preventive options of persons who are not their patients.
Rigo A; Stuy J
Ann N Y Acad Sci; 1999; 889():256-61. PubMed ID: 10668503
[No Abstract] [Full Text] [Related]
6. Support groups for people carrying a BRCA mutation.
Dorval M; Maunsell E; Dugas MJ; Simard J
CMAJ; 2001 Sep; 165(6):740; author reply 740, 742. PubMed ID: 11584558
[No Abstract] [Full Text] [Related]
7. A rapid immunoassay predicts BRCA1 and BRCA2 mutations in buccal cells.
Byrne TJ; Reece MT; Adams LA; Hoffman DE; Lane MA; Cohn GM
Oncol Rep; 2000; 7(6):1203-7. PubMed ID: 11032914
[TBL] [Abstract][Full Text] [Related]
8. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
Lerman C; Hughes C; Lemon SJ; Main D; Snyder C; Durham C; Narod S; Lynch HT
J Clin Oncol; 1998 May; 16(5):1650-4. PubMed ID: 9586874
[TBL] [Abstract][Full Text] [Related]
9. BRCA genes--bookmaking, fortunetelling, and medical care.
Healy B
N Engl J Med; 1997 May; 336(20):1448-9. PubMed ID: 9145684
[No Abstract] [Full Text] [Related]
10. BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women.
Gilbert F; Dabney MK; Diemer K; Ludwig S; Rosenthal G; Osborne MP
Ann N Y Acad Sci; 1997 Dec; 833():198-203. PubMed ID: 9616755
[No Abstract] [Full Text] [Related]
11. [Pregnancy and risk of early breast cancer in patients sith BRCA1 and BRCA2 mutations].
Ost E; Illiger HJ
Strahlenther Onkol; 2000 Jul; 176(7):335-6. PubMed ID: 10963002
[No Abstract] [Full Text] [Related]
12. BRCA mutations and survival in breast cancer.
Foulkes WD; Wong N; Brunet JS; Narod SA
J Clin Oncol; 1998 Sep; 16(9):3206-8. PubMed ID: 9738598
[No Abstract] [Full Text] [Related]
13. Mutation testing of early-onset breast cancer genes BRCA1 and BRCA2.
Neuhausen SL; Ostrander EA
Genet Test; 1997; 1(2):75-83. PubMed ID: 10464630
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
[TBL] [Abstract][Full Text] [Related]
15. The genetics of breast cancer: can we use today's information?
Bell NN
Manag Care Interface; 1998 May; 11(5):52-6. PubMed ID: 10181553
[No Abstract] [Full Text] [Related]
16. Breast cancer genes--what are the real risks?
Easton D
Nat Genet; 1997 Jul; 16(3):210-1. PubMed ID: 9207777
[No Abstract] [Full Text] [Related]
17. Genetic counseling for BRCA1/BRCA2 testing.
Schneider KA
Genet Test; 1997; 1(2):91-8. PubMed ID: 10464632
[TBL] [Abstract][Full Text] [Related]
18. NCI-Myriad agreement offers BRCA testing at reduced cost.
Reynolds T
J Natl Cancer Inst; 2000 Apr; 92(8):596. PubMed ID: 10772669
[No Abstract] [Full Text] [Related]
19. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.
Zweemer RP; Shaw PA; Verheijen RM; Ryan A; Berchuck A; Ponder BA; Risch H; McLaughlin JR; Narod SA; Menko FH; Kenemans P; Jacobs IJ
J Clin Pathol; 1999 May; 52(5):372-5. PubMed ID: 10560359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
